Skip to content

Apotheek Van Assche

Active
Private limited companyfounded 201115 yrs activeBoudewijnlaan 92, 2243 Zandhoven, BelgiumKBO/BCE: BE 0832.466.074

Apotheek Van Assche has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €631k and a net result of €18k. Equity remains stable across the filed fiscal years (±1.1% per year). Its solvency ranks better than 54% of 10242 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).

Checked score

Score 2025
87 / 100
Excellent▲ +8 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability14▲+12
Solvency85▼-1
Growth52=
Stability100
Bankruptcy probability, 12 months
0.6% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €55k at 30 days acceptable
Liquidity ample (current ratio 4.25 against 2.98 in 2024), but 58.8% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
41.2%
Return on assets
1.1%
Age of the figures
8 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 15 years 0 20 y
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-08-2026, 20 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
20 d late
2024
3 d early
2023
14 d late
2022
4 d early
2021
23 d late
2020
24 d late
2019
28 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
15-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, abbreviated schema

Equity
€631k▲ 2.9%
2024 · €614k
2018: €579k 2019: €579k 2020: €610k 2021: €603k 2022: €605k 2023: €611k 2024: €614k
2018 → 2025
Total assets
€1.53M▲ 4.3%
2024 · €1.47M
2018: €1.23M 2019: €1.09M 2020: €742k 2021: €1.02M 2022: €1.11M 2023: €1.03M 2024: €1.47M
2018 → 2025
Net result
€18k▲ 619%
2024 · €2k
2018: €152k 2019: €152k 2020: €31k 2021: €-7k 2022: €102k 2023: €56k 2024: €2k
2018 → 2025
Working capital
€478k▲ 8.6%
2024 · €440k
2018: €271k 2019: €321k 2020: €425k 2021: €438k 2022: €453k 2023: €483k 2024: €440k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€603k-€605k▲ 0.4%€611k▲ 1.1%€614k▲ 0.4%€631k▲ 2.9%
Operating result€16k-€132k▲ 744%€85k▼ 35.6%€24k▼ 71.5%€51k▲ 110%
Net result€-7k-€102k€56k▼ 44.8%€2k▼ 95.7%€18k▲ 619%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€-50k€0€50k€100k€150kOperating result 2021: €16k€16kNet result 2021: €-7k€-7kOperating result 2022: €132k€132kNet result 2022: €102k€102kOperating result 2023: €85k€85kNet result 2023: €56k€56kOperating result 2024: €24k€24kNet result 2024: €2k€2kOperating result 2025: €51k€51kNet result 2025: €18k€18k20212022202320242025
The operating result recovers in 2025; 2025 is 110% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.53M
Fixed assets €909k▲ 12.5%
Current assets €625k▼ 5.7%
Equity and liabilities €1.53M
Equity €631k▲ 2.9%
Debt €902k▲ 5.3%
The debt ratio rises from 58.2% to 58.8%: debt grows faster than equity.
Key figures and ratios
2025 value · change against 2024
EBITDA
€103k
2024 · €65k
Cash flow
€70k
2024 · €43k
Solvency
41.2%
2024 · 41.8%
Current ratio
4.25
2024 · 2.98
Quick ratio
2.56
2024 · 1.93
Debt / equity
1.43
2024 · 1.40
ROE
2.8%
2024 · 0.4%
ROA
1.1%
2024 · 0.2%
Interest coverage
3.47
2024 · 5.39
Debt
€902k
2024 · €856k
Debt ≤ 1 year
€147k
2024 · €222k
Debt > 1 year
€755k
2024 · €634k
Income taxes
€4k
2024 · €10k
Staff costs
€246k
2024 · €239k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€1.47M€1.53M
Fixed assets21/28€808k€909k
Tangible fixed assets22/27€808k€909k
Land and buildings22€794k€750k
Plant, machinery and equipment23€14k€159k
Current assets29/58€663k€625k
Stocks and contracts in progress3€235k€249k
Stocks30/36€235k€249k
Amounts receivable within one year40/41€155k€227k
Trade receivables40€130k€170k
Other amounts receivable41€24k€57k
Cash at bank and in hand54/58€253k€121k
Deferred charges and accrued income490/1€21k€28k
Equity and liabilities
Total equity and liabilities10/49€1.47M€1.53M
Equity10/15€614k€631k
Contributions10/11€19k€19k=
Reserves13€595k€613k
Tax-exempt reserves132€39€39=
Distributable reserves133€595k€613k
Profit (loss) carried forward14€0-
Amounts payable17/49€856k€902k
Amounts payable after more than one year17€634k€755k
Financial debts170/4€634k€755k
Amounts payable within one year42/48€222k€147k
Current portion of amounts payable after more than one year42€29k€29k
Trade debts44€85k€68k
Suppliers440/4€85k€68k
Taxes, remuneration and social security45€37k€17k
Remuneration and social security454/9€37k€17k
Other amounts payable47/48€72k€33k
Income statement Code20242025
Remuneration, social security and pensions62€239k€246k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€40k€52k
Other operating charges640/8€5k€4k
Gross operating margin9900€309k€353k
Operating profit (loss)9901€24k€51k
Financial charges65/66B€12k€30k
Recurring financial charges65€12k€30k
Profit (loss) for the period before taxes9903€12k€21k
Income taxes67/77€10k€4k
Profit (loss) for the period9904€2k€18k
Profit (loss) for the period to be appropriated9905€2k€18k
Appropriation of the result
Profit (loss) to be appropriated9906€2k€18k
Transfer to equity691/2€2k€18k
To other reserves6921€2k€18k
Profit to be distributed694/7€0-
Return on contributions (dividend)694€0-
Social balance
Average headcount (FTE)90873.53.6

The notes to these accounts (16 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
20-08
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema · 20 days late
2025
28-07
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
14-08
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema · 14 days late
2023
27-07
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial Back to profitnet €102k
Net result €102k after one loss-making year.
23-08
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema · 23 days late
2021
31-12
Financial Weakest financial yearnet €-7k ▼123%
Net result drops to €-7k, the lowest in the series; recovery starts the following year.
24-08
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema · 24 days late
2020
31-12
Financial Liquidity doublescurrent ratio 4.23
Current ratio from 1.80 to 4.23; short-term debt falls from €401k to €131k.
28-08
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema · 28 days late
2019
08-08
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema · 8 days late
2018
30-07
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
22-08
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema · 22 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
7 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Zandhoven · 1 establishment unit since 2011
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Boudewijnlaan 922243 Zandhoven
Ground area
425 m²
Building footprint
204 m²
Volume, LiDAR
1,117 m³
Parcel 11034B0113/00V000, Flanders · tallest building 9.0 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Apotheek Van Assche
Boudewijnlaan 92, 2243 ZandhovenRetail sale of pharmaceutical products
since 20112.194.957.174
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
11034B0113/00V000 Flanders 425 m² 1 · 204 m² 9.0 m · 2 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Food safety, FASFC

1 site
Zandhoven2.194.957.174
1 permission
Apotheek (LM>3 maand) · since 05-01-2011

Similar companies · same sector, comparable size

Of 5,209 companies in sector 47730 we hold annual accounts for 3,851. 3,260 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded05-01-2011
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
96022Beauty treatment
96220Beauty care and other beauty treatments
Sources
Crossroads Bank for EnterprisesNational Bank · 15 filingsAddress and cadastre registers

Data from official sources, last processed on 14-09-2026. Scores and ratios are computed by Checked and are not a credit decision.